SuperworthInovio Pharmaceuticals shares outstanding INO
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 81.6M
- On a year earlier
- +110.2%
- more shares
Inovio Pharmaceuticals had 81.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 110.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 61.9M | +106% |
| FY2024 | 30M | +32% |
| FY2023 | 22.7M | +9% |
| FY2022 | 20.9M | +18% |
| FY2021 | 17.7M | +22% |
| FY2020 | 14.5M | +74% |
| FY2019 | 8.4M | +4% |
| FY2018 | 8M | +6% |
| FY2017 | 7.5M | +22% |
| FY2016 | 6.2M | +3% |
| FY2015 | 6M | +19% |
| FY2014 | 5.1M | +17% |
| FY2013 | 4.3M | +48% |
| FY2012 | 2.9M | +9% |
| FY2011 | 2.7M | +24% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 81.6M | +110% | |
| Q1 FY26 | 69.1M | +79% | |
| Q4 FY25 | 61.9M | +106% | |
| Q3 FY25 | 52.2M | +85% | |
| Q2 FY25 | 38.8M | +43% | |
| Q1 FY25 | 38.6M | +66% | |
| Q4 FY24 | 30M | +32% | |
| Q3 FY24 | 28.1M | +26% | |
| Q2 FY24 | 27.2M | +23% | |
| Q1 FY24 | 23.3M | +8% | |
| Q4 FY23 | 22.7M | +9% | |
| Q3 FY23 | 22.4M | +8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Inovio Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.